Literature DB >> 20541770

Peripheral biomarkers and illness activity in bipolar disorder.

Flávio Kapczinski1, Felipe Dal-Pizzol, Antonio Lucio Teixeira, Pedro V S Magalhaes, Márcia Kauer-Sant'Anna, Fábio Klamt, José Claudio F Moreira, Mateus Augusto de Bittencourt Pasquali, Gabriel Rodrigo Fries, João Quevedo, Clarissa Severino Gama, Robert Post.   

Abstract

Recent evidence suggests that peripheral markers related to oxidative stress, inflammation and neurotrophins may be altered during mood episodes in bipolar disorder. These can be seen as proxies of peripheral toxicity or markers of illness activity. Here we report an en bloc assessment of a set of previously described biomarkers in different mood states (n = 60) as well as in healthy subjects (n = 80). To make the point that these are ominous changes, we obtained the same measures from a group of septic patients (n = 15) as a "positive" control group. In this sample, we measured serum levels of brain derived neurotrophic factor, neurotrophin 3, tumor necrosis factor α, interleukin 6, interleukin 10, total reactive antioxidant potential, thiobarbituric acid reactive substances and protein carbonyl content. Several of the markers discriminated between the bipolar and control groups, especially when patients were in acute episodes. In some cases, toxicity was as high in bipolar disorder as that seen in patients with sepsis. We believe these findings highlight the potential of using biomarkers to assess illness activity in bipolar disorder. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541770     DOI: 10.1016/j.jpsychires.2010.05.015

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  53 in total

Review 1.  Bipolar Depression and Cognitive Impairment: Shared Mechanisms and New Treatment Avenues.

Authors:  Colin A Depp; Sheena Dev; Lisa T Eyler
Journal:  Psychiatr Clin North Am       Date:  2015-12-11

Review 2.  Review of quantitative phase-digital holographic microscopy: promising novel imaging technique to resolve neuronal network activity and identify cellular biomarkers of psychiatric disorders.

Authors:  Pierre Marquet; Christian Depeursinge; Pierre J Magistretti
Journal:  Neurophotonics       Date:  2014-09-22       Impact factor: 3.593

Review 3.  Staging and neuroprogression in bipolar disorder.

Authors:  Gabriel Rodrigo Fries; Bianca Pfaffenseller; Laura Stertz; André Vinicius Contri Paz; Aroldo Ayub Dargél; Maurício Kunz; Flávio Kapczinski
Journal:  Curr Psychiatry Rep       Date:  2012-12       Impact factor: 5.285

4.  Preventive Effect of Cecropia pachystachya Against Ketamine-Induced Manic Behavior and Oxidative Stress in Rats.

Authors:  Marta Gazal; Fernanda N Kaufmann; Bruna A Acosta; Pathise Souto Oliveira; Matheus R Valente; Caroline Flach Ortmann; Régis Sturbelle; Claiton L Lencina; Francieli M Stefanello; Manuella P Kaster; Flávio Henrique Reginatto; Gabriele Ghisleni
Journal:  Neurochem Res       Date:  2015-05-22       Impact factor: 3.996

5.  A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression.

Authors:  D R Goldsmith; M H Rapaport; B J Miller
Journal:  Mol Psychiatry       Date:  2016-02-23       Impact factor: 15.992

6.  Proinflammatory Cytokines, Mood, and Sleep in Interepisode Bipolar Disorder and Insomnia: A Pilot Study With Implications for Psychosocial Interventions.

Authors:  Michael R Dolsen; Adriane M Soehner; Allison G Harvey
Journal:  Psychosom Med       Date:  2018-01       Impact factor: 4.312

Review 7.  [Oxidative stress in bipolar affective disorder].

Authors:  E Z Reininghaus; S Zelzer; B Reininghaus; N Lackner; A Birner; S A Bengesser; F T Fellendorf; H-P Kapfhammer; H Mangge
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

Review 8.  Inflammatory mediators of cognitive impairment in bipolar disorder.

Authors:  Isabelle E Bauer; Michaela C Pascoe; Bianca Wollenhaupt-Aguiar; Flavio Kapczinski; Jair C Soares
Journal:  J Psychiatr Res       Date:  2014-05-02       Impact factor: 4.791

9.  Abnormal gene expression of proinflammatory cytokines and their receptors in the lymphocytes of patients with bipolar disorder.

Authors:  Ghanshyam N Pandey; Xinguo Ren; Hooriyah S Rizavi; Hui Zhang
Journal:  Bipolar Disord       Date:  2015-08-08       Impact factor: 6.744

10.  Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder.

Authors:  Gustavo Scola; Robert K McNamara; Paul E Croarkin; Jarrod M Leffler; Kathryn R Cullen; Jennifer R Geske; Joanna M Biernacka; Mark A Frye; Melissa P DelBello; Ana C Andreazza
Journal:  J Affect Disord       Date:  2015-12-23       Impact factor: 4.839

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.